IN8BIO, INC. (INAB) has 23 open-market insider trades by 19 insiders since 2021. The most active filer is Transcend Partners Opportunity Fund LLC, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| BIOS Fund II, LP | Dir10% Owner | — | 1 | $6.7M | 2022-08-16 |
| Transcend Partners Opportunity Fund LLC | Dir10% Owner | — | 2 | $4.0M | 2022-08-16 |
| BIOS Advisors GP, LLC | Dir10% Owner | — | 1 | $3.4M | 2022-08-16 |
| Peter C. Brandt | Dir | — | 1 | $400K | 2025-12-22 |
| Leslie W. Kreis | Dir10% Owner | — | 1 | $327K | 2022-12-12 |
| BIOS Fund III QP, LP via Leslie W. Kreis | Dir10% Owner | — | 1 | $186K | 2022-12-12 |
| Cavu Management, LP | Dir10% Owner | — | 1 | $170K | 2022-08-17 |
| Cavu Advisors, LLC | Dir10% Owner | — | 1 | $165K | 2022-08-29 |
| BIOS Fund II NT, LP | Dir10% Owner | — | 2 | $147K | 2022-09-28 |
| BIOS Fund II QP, LP | Dir10% Owner | — | 1 | $103K | 2024-10-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jeremy R. Graff | Director | Buy | $2K | 2023-09-13 |
| Patrick McCall | CFO | Buy | $1K | 2023-08-25 |
| William Tai-Wei Ho | President & 10% | Buy | $25K | 2023-08-24 |
| BIOS Fund III QP, LP | Director & 10% | Buy | $186K | 2022-12-12 |
| Leslie W. Kreis | Director & 10% Owner | Buy | $327K | 2022-12-12 |
| Bios Equity Partners II, LP | Director & 10% | Buy | $51K |
Companies that share insiders with INAB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-09-28 |
| Cavu Advisors, LLC | Director & 10% Owner | Buy | $165K | 2022-08-26 |
| BIOS Fund II QP, LP | Director & 10% | Buy | $103K | 2022-08-26 |
| BIOS Fund II NT, LP | Director & 10% | Buy | $97K | 2022-08-17 |
| Cavu Management, LP | Director & 10% Owner | Buy | $170K | 2022-08-17 |
| Peter C. Brandt | Director | Buy | $400K | 2022-08-16 |
| Transcend Partners Opportunity Fund LLC | Director & 10% Owner | Buy | $3.0M | 2022-08-16 |
| Alan S. Roemer | Director | Buy | $50K | 2022-08-16 |
| Luba Greenwood | Director | Buy | $999 | 2022-08-16 |
| BIOS Advisors GP, LLC | Director & 10% | Buy | $3.4M | 2022-08-16 |